0001209191-24-003348.txt : 20240214 0001209191-24-003348.hdr.sgml : 20240214 20240214160123 ACCESSION NUMBER: 0001209191-24-003348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sands Stephen H. CENTRAL INDEX KEY: 0001913319 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 24637479 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING A, SUITE 510 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-09 0 0001662244 Cyteir Therapeutics, Inc. CYT 0001913319 Sands Stephen H. C/O CYTEIR THERAPEUTICS, INC. 99 HAYDEN AVE, BUILDING B, SUITE 450 LEXINGTON MA 02421 1 0 0 0 0 Common Stock 2024-02-09 4 M 0 12129 1.69 A 12129 D Stock Option (Right to Buy) 1.69 2024-02-09 4 M 0 12129 0.00 D 2024-02-03 2033-02-03 Common Stock 12129 0 D /s/ David Gaiero, as attorney-in-fact for Stephen Sands 2023-02-14